J. Derek Lewis & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
2,249
+218
+11% +$25.5K 0.05% 146
2026
Q1
$244K Sell
2,031
-1
-0% -$115 0.06% 153
2025
Q4
$214K Buy
+2,032
New +$191K 0.05% 168

Other funds holding MRK

J. Derek Lewis & Associates's MRK Position: Q2 2026 in Review

J. Derek Lewis & Associates increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $25.5K and bringing the position to 2,249 shares worth $289K. The position accounts for 0.05% of the portfolio, ranked #146.

J. Derek Lewis & Associates first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 2,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • J. Derek Lewis & Associates held 2,249 shares of Merck worth $289K as of Q2 2026.
  • J. Derek Lewis & Associates bought 218 Merck shares in Q2 2026, an estimated $25.5K.
  • Merck made up 0.05% of J. Derek Lewis & Associates's portfolio in Q2 2026, its #146 holding.
  • J. Derek Lewis & Associates first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 2,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on J. Derek Lewis & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.